Market Cap (In TWD)
491.68 Million
Revenue (In TWD)
103.22 Million
Net Income (In TWD)
-21.81 Million
Avg. Volume
100.66 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 11.8-19.65
- PE
- -
- EPS
- -
- Beta Value
- 0.626
- ISIN
- TW0006621006
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yu-Shan Wang Ph.D.
- Employee Count
- -
- Website
- https://www.uni-pharma.com
- Ipo Date
- 2017-08-18
- Details
- UniPharma Co., Ltd. engages in the distribution of pharmaceutical drugs, medical devices, and diagnostic tests in Taiwan. The company provides diagnostic tests in areas of oncology, gynecology, orthopedics, neurology, anesthesiology, and cardiology. It offers Adept reduction solution; bain, esmolol HCI, and naloxone anesthesia injections; Elisa DR-70 test for in-vitro diagnostics of tumors; and fomeject antidote injection, as well as drug development, research and development, clinical trials, marketing, and other business services. It serves medical centers, regional and area hospitals, and clinics. UniPharma Co., Ltd. was incorporated in 1998 and is based in Taipei, Taiwan.
More Stocks
-
UJJIVANSFBUjjivan Small Finance Bank Limited
UJJIVANSFB
-
BMGB4Banco BMG S.A.
BMGB4
-
UPMMYUPM-Kymmene Oyj
UPMMY
-
8941
-
ACIUAC Immune SA
ACIU
-
3434
-
0720
-
THMO